Track Your CD4 Count and Viral Load! Use TheBody.com's New Health Tracker!

HIV/AIDS Basics & Prevention

Just Diagnosed

HIV Treatment

Living With HIV

AIDS Policy & Activism

HIV Around the World

Conference Coverage

Ziagen (Abacavir)

The Basics | News | Research

Show Archived (Historical) Articles

Brand Name:	Ziagen
Generic Name:	Abacavir, ABC
Adult Single Dose:	One 300-mg tablet (twice a day) or two 300-mg tablets (once a day)
Food & Liquid Restrictions:	None
Drug Class:	NRTI

The Basics

An Overview of Ziagen (Abacavir) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health
Ziagen (March/April 2009)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
Ziagen (Abacavir) (September 28, 2008)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
Abacavir (Ziagen) (August 23, 2008)
To read PDF, click here
From AIDS InfoNet
Abacavir (Ziagen) (July 15, 2008)
From AIDS Treatment Data Network
Patient Information About Ziagen (Abacavir) (PDF) (July 2008)
From GlaxoSmithKline
Ziagen (Abacavir) (May 2005)
To read PDF, click here
From The Center for AIDS
Drug Interactions: Abacavir (August 2004)
From Project Inform

News

Ziagen 300 mg Scored Tablet Facilitates Pediatric Treatment of Infection With HIV (December 19, 2008)
From U.S. Food and Drug Administration
GlaxoSmithKline Announces New Program to Provide Financial Assistance for Eligible HIV Patients in the U.S. (November 11, 2008)
If you live in the United States, use private health insurance and take Combivir (AZT/3TC), Epzicom (abacavir/3TC, Kivexa), Lexiva (fosamprenavir, Telzir) or another HIV drug made by GlaxoSmithKline, you may have a chance to save a nice chunk of change.
From GlaxoSmithKline
Important Safety-Related Label Update for Ziagen (Abacavir Sulfate) (July 18, 2008)
From U.S. Food and Drug Administration
Ziagen's Heart Attack Link: How Long Has Glaxo Known? (May 12, 2008)
In The Independent
Guidelines Panel Responds to Abacavir Data (April 10, 2008)
From Project Inform
Early Communication About an Ongoing Safety Review of Ziagen (Abacavir) and Videx (Didanosine) (March 27, 2008)
From U.S. Food and Drug Administration
Ziagen Pills Found in Fake Combivir Packaging (March 29, 2007)
To read PDF, click here
From GlaxoSmithKline
Two New Fixed-Dose Combinations Approved (August 2, 2004)
From U.S. Food and Drug Administration
Drug Development News: Fixed-Dose Combinations (May/June 2004)
The Food and Drug Administration's fast-track approval process for fixed-dose combinations is about to bear fruit.
In GMHC Treatment Issues, from Gay Men's Health Crisis

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.